Breaking News

Theorem Promotes Veteran Researcher

September 10, 2013

Lake to lead respiratory biopharma franchise

Phil Lake has been appointed executive director of biopharmaceutical development, respiratory, at Theorem Clinical Research. Mr. Lake will be responsible for senior oversight on major projects as well as building the company’s respiratory business globally.
Mr. Lake joined Theorem as senior director of project management in 2012. He has held positions including managing director of Springfield Clinical Consulting, executive director of project management in Europe for Covance and as senior clinical research manager for GlaxoSmithKline in London. He has significant therapeutic experience in respiratory disorders, including numerous COPD and asthma studies.
“Phil Lake has been a tremendous asset to our European operations, and I am confident he has the contacts and experience to take our biopharmaceuticals division to the next level,” said Theorem president and chief executive officer, John Potthoff.
blog comments powered by Disqus
  • The Role of Value in Drug Pricing

    The Role of Value in Drug Pricing

    Keren Shani, Ryan Million, Trinity Partners ||October 11, 2016
    Exploring the trend of using frameworks and models to evaluate the value of a drug

  • CRO-Sponsor Partnerships

    CRO-Sponsor Partnerships

    Craig Morgan, Brand Development Director, goBalto Inc.||October 11, 2016
    10 tips for enabling better CRO and sponsor collaborations

  • The Human Parts of Mouse Models

    The Human Parts of Mouse Models

    Julia Schueler, Head of in vivo Operations, Oncotest, a Charles River company ||October 11, 2016
    The PDX model system has come back into focus